Sienna Announces Fourth Quarter 2023 Results Release Date and Conference Call
MARKHAM, Ontario, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) announced that it will report its 2023 fourth quarter results after market close on Tuesday, February 20, 2024. Nitin Jain, President and Chief Executive Officer, and David Hung, Chief Financial Officer and Executive Vice President, will host a conference call for the investment community the following day, Wednesday, February 21, 2024 at 9:30 a.m. (ET).
The toll-free dial-in number for participants is 1-800-715-9871, conference ID: 6738823. A webcast of the call will be accessible via Sienna's website. The webcast of the call will be available for replay until February 20, 2025 and archived on Sienna's website.
About Sienna Senior Living
Sienna Senior Living Inc. (TSX:SIA) offers a full range of senior living options, including independent living, assisted living and memory care under its Aspira retirement brand, long-term care, and specialized programs and services. Sienna's approximately 12,000 employees are passionate about cultivating happiness in daily life. For more information, please visit www.siennaliving.ca.
For further information, please contact: Nancy Webb Senior Vice President, Public Affairs & Marketing 905-489-0788 [email protected]
With tremendous support from Canada's seven National Hockey League (NHL) teams, individuals and several communities, the ALS Super Fund has achieved a significant milestone: surpassing its first $1 million in donations through Charitable Impact's...
DermTech, Inc. (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported its first-quarter 2024 financial results.
First-Quarter 2024 Financial Results
Billable sample volume...
Calidi Biotherapeutics Inc. ("Calidi"), a clinical-stage biotechnology company developing a new generation of targeted virotherapies, today reported its first quarter 2024 operating and financial results and reviewed recent business highlights....
ENDRA Life Sciences Inc. , a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three months ended March 31, 2024 and provided a business update.
Highlights from the first quarter of 2024 and recent...
Pulse Biosciences, Inc. , a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology ("Pulse"), today announced enhancements to its executive leadership team to support its next pivotal phase of...
Moffitt Cancer Center, a world-renowned cancer treatment and research center, and Fulgent Pharma, a subsidiary of Fulgent Genetics, Inc. and a leading nanobiotechnology company specializing in innovative cancer therapeutics, announced today a...
